Navigation Links
Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
Date:7/13/2014

sp;   Blood Clots
  •     Death
  • Xarelto is a blood thinner that is used for a number of indications, including the prevention of blood clots related to atrial fibrillation, and the treatment of dangerous blood clots called deep vein thrombosis and pulmonary embolism. It is also given to patients who have just had hip or knee replacement surgery to reduce the risk of blood clots in the legs and lungs. Xarelto was approved by the U.S. Food & Drug Administration (FDA) in 2011, and is manufactured by Bayer HealthCare. Janssen Pharmaceutical, a division of Johnson & Johnson, markets Xarelto in the U.S.
    (fda.gov/downloads/Drugs/DrugSafety/
    UCM280333.pdf, FDA, March 2014)

    All blood thinners, including Xarelto, can cause patients to suffer internal hemorrhaging. However, there currently exists no antidote to reverse Xarelto bleeding. Since its approval, the drug has been the subject of several FDA safety alerts. In August 2013, a boxed warning was added to the Xarelto label advising that premature discontinuation of the drug increases the risk of thrombotic events. The FDA also warned that epidural or spinal hematomas with the potential to cause long-term or permanent paralysis could occur in Xarelto patients who receive anesthesia or undergo spinal puncture.
    (fda.gov/safety/medwatch/safetyinformation/ucm367392.htm, FDA, March 2014)

    According to a report published by Reuters last month, at least 10 Xarelto lawsuit claims have been filed in U.S. courts on behalf of patients who may have been injured by the blood thinner. Most recently, a Florida woman filed a wrongful death lawsuit on behalf of her husband, who allegedly died due to uncontrollable bleeding caused by Xarelto. Among other things, the complaint, which was filed on June 23, 2014 in U.S. District Court, Southern District of Florida, claims that the manufacturers of Xarelto failed to warn that there was no reve
    '/>"/>

    Source: PRWeb
    Copyright©2014 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related medicine news :

    1. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
    2. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure
    3. DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant
    4. Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns
    5. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing
    6. Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators
    7. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
    8. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal C.R. Bard Litigation
    9. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
    10. Best Transvaginal Mesh Attorneys? LawsuitLegal.com Now Accepting Surgical Mesh Failure Victim Inquiries
    11. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Recall Litigation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... ... 2015 , ... Rhode Island Medical Imaging (RIMI) is pleased to announce the ... Wake Robin Road in Lincoln, RI. This satellite office will provide x-ray and ... out-patient x-ray hours in the state, which includes evenings and weekends. , “This ...
    (Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... capsule formula. Healthy Origins® Cognizin® is a trademark for Citicoline, a nutrient ... for a capsule for those applications which have more of a semi-solid composition. ...
    (Date:8/4/2015)... ... August 04, 2015 , ... Ryadon Inc. will ... Finding reliable hardware can be difficult and troublesome for companies. Without dependable ... or designing a new facility, it is imperative to include only the finest, ...
    (Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Angelina Jolie ... that affects millions of women every year. Dr. Angela DeRosa, DO, MBA, CPE ... hormone replacement therapies, takes the scary unknown out of menopause. , Myth #1: ...
    (Date:8/4/2015)... , ... August 04, 2015 , ... ... the United States, Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors ... and will save lives," Dr. Carmona said. "I strongly believe in the mission ...
    Breaking Medicine News(10 mins):Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3
    ... , , New York ,s Automobile Insurance System Is Currently ... Feb. 3 Fraud and abuse in New York ... million in 2009, constituting a "fraud tax" of $1,561 , ... Hartwig , an economist and president of the Insurance Information Institute ...
    ... explain memory and other problems related to disorder, study ... with severe obstructive sleep apnea have reduced concentrations of ... research shows. , Gray matter refers to the brain,s ... place. These changes in brain structure may help explain ...
    ... DANVILLE, Pa. Feb. 3, 2010 The Translational Genomics ... signing of a strategic research agreement that provides for a ... research can make a difference. One of the first ... other metabolic conditions. Researchers plan to look at the possible ...
    ... AdvanceMarketWoRx ... ... and consumer healthcare marketers have a new resource to look to for advice on ... titled “Best Learning Actions for Healthcare Marketers in 2010,” is the first of its ...
    ... , Held at 2,000 U.S. locations during National ... Feb. 3 With an economy that might cause some ... decay being the most prevalent chronic disease in America,s children, the ... the eighth consecutive year in a national campaign to extend necessary ...
    ... , CLEVELAND , Feb. 3 Twenty ... a recent survey by Herbruck Alder, a Cleveland -based ...  This is an increase of seven percent over the results ... Third Annual Employer Wellness Survey, another 17 percent of respondents ...
    Cached Medicine News:Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 2Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 3Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 4Health News:Brain Damage Seen in People With Severe Sleep Apnea 2Health News:TGen and Geisinger Health System announce strategic partnership 2Health News:TGen and Geisinger Health System announce strategic partnership 3Health News:Six Key Areas of Learning for Pharmaceutical and Healthcare Marketing in 2010 2Health News:Six Key Areas of Learning for Pharmaceutical and Healthcare Marketing in 2010 3Health News:Six Key Areas of Learning for Pharmaceutical and Healthcare Marketing in 2010 4Health News:Eighth Annual 'Give Kids A Smile' Day Provides Free Dental Care to Children 2Health News:Eighth Annual 'Give Kids A Smile' Day Provides Free Dental Care to Children 3Health News:Herbruck Alder Survey Reveals More Northern Ohio Companies Offering Employee Wellness Programs 2Health News:Herbruck Alder Survey Reveals More Northern Ohio Companies Offering Employee Wellness Programs 3
    (Date:8/4/2015)... N.J. and LOS ANGELES ... Diagnostics (NYSE: DGX ), the world,s leading ... it has completed the previously announced acquisition of ... As a result of the transaction, ... extensive range of innovative services and network of ...
    (Date:8/4/2015)... 2015  Sutro Biopharma today announced that it ... vice president of alliance and project management. Dr. ... management of Sutro,s collaborative partnerships and the development ... bispecific antibodies and antibody-based therapeutics targeting immuno-oncology pathways. ... years of experience in the biopharmaceutical sector with ...
    (Date:8/4/2015)... 4, 2015  Delcath Systems, Inc. (NASDAQ: DCTH ... on oncology with an emphasis on the treatment of ... summarizing data from studies in Europe ... Hepatic CHEMOSAT ® Delivery System (CHEMOSAT) will be presented ... congress, which will be held in Marseille, ...
    Breaking Medicine Technology:Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 4
    ... Inc., a neurology-focused specialty pharmaceutical company, announced today that ... of CAMBIA™ (diclofenac potassium for oral solution) will be ... Neurology Conference (CONy) in Barcelona, Spain. The ... entitled, "Rapid and Sustained Improvement in Migraine Symptoms with ...
    ... joint guideline by the American Society of Hematology (ASH) ... physicians about the appropriate use of erythropoiesis-stimulating agents (ESAs), ... to produce more red blood cells, to treat cancer ... ESAs are associated with shorter survival and increased risk ...
    Cached Medicine Technology:New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 2New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 3New Analysis of CAMBIA™ Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology 4New Guideline from ASH and ASCO Recommends Caution Regarding ESA Use in Cancer Patients 2New Guideline from ASH and ASCO Recommends Caution Regarding ESA Use in Cancer Patients 3
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: